Investing Legend Hints the End May Be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Questions emerge about NYC gunman's mental health and his security-sensitive job in Las Vegas
LAS VEGAS (AP) — The man who stormed a Manhattan office tower with a gun, before killing himself, worked in the surveillance department of a Las Vegas casino, part of an industry built on watching for threats before they unfold.
US health officials crack down on kratom-related products after complaints from supplement industry
WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-like ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
A Florida woman posed as a nurse and treated thousands of unsuspecting patients, officials say
PALM COAST, Fla. (AP) — A Florida woman is accused of posing as a licensed nurse and giving medical care to thousands of patients, authorities said.
Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins
Tempus AI beat Q2 estimates with 90% revenue growth, narrowed losses, and a raised 2025 outlook driven by strong genomics and data services gains.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
RFK Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON (AP) — Health Secretary is vowing to “fix” the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by .
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate heart devices recently linked to injuries and deaths.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Compounded GLP-1s And Competition Force Novo Nordisk To Slash Outlook
Novo Nordisk reported Q2 sales of $11.7 billion, missing consensus. Sales increased by 13% in Danish kroner, driven by GLP-1 diabetes and obesity care sales.
Bryan Johnson Spent Millions To Be 18 Again—Says Novo Nordisk's Ozempic Anti-Aging Hype Is Misleading: 'Data Is Not There'
Tech entrepreneur Bryan Johnson refutes claims that Novo Nordisk AS's Ozempic demonstrates anti-aging properties.
Is Your Capital Following a Real Strategy? - Ad
Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.
Nations will try again on plan to confront world's 'spiraling' plastic pollution mess
Nations gather in Geneva Tuesday to try to complete a landmark treaty aimed at ending the that affects every ecosystem and person on the planet.
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
TG Therapeutics missed Q2 earnings and revenue expectations but raised its 2025 Briumvi sales guidance following strong global growth.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
AMA and other medical associations are kicked out of CDC vaccine workgroups
NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations.
Asian shares retreat after Trump's order imposing new tariffs on 68 countries and the EU
MANILA, Philippines (AP) — Asian shares retreated Friday following that saw more losses as investors assess President Donald Trump's order in seven days.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses
CVS Health topped Wall Street expectations for the second quarter and hiked its , as the health care giant continued to rally under new management from a forgettable 2024.
Trump administration is launching a new private health tracking system with Big Tech's help
WASHINGTON (AP) — The administration is pushing an initiative for millions of Americans to upload personal health data and medical records on new apps and systems run by private tech companies, promising that will make it easier to access health records and
Nvidia CEO Makes First Ever Tesla Announcement - Ad
While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.
Assisted-living facility where fire killed 10 temporarily lost certification for mistreatment
A Massachusetts where a fire killed 10 people earlier this month temporarily lost its certification nearly a decade ago due to resident mistreatment, according to state regulators.
FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
The Surprising New Date That Could Fuel the AI Boom - Ad
Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.
Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state
LITTLE ROCK, Ark. (AP) — A federal judge temporarily blocked on Monday Arkansas' first-in-the-nation law that pharmacy benefit managers from owning pharmacies in the state.
Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks
HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR antibody-positive gMG.
AP Exclusive: UN chief says market forces point the way to curbing climate change
NEW YORK (AP) — For nearly a decade United Nations Secretary-General Antonio Guterres has been using science to warn about evermore dangerous in increasingly urgent tones. Now he's enlisting something seemingly more important to the world's powerful: Money.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Sweetening soft drinks: What to know about sugar, high-fructose corn syrup and their alternatives
President Donald Trump last week, but the Coca-Cola Co. Tuesday: a cane sugar-sweetened version of the beverage maker's trademark soda will be released in the U.S. this fall.
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and drug advertising rules.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Sarepta's Shocking Stand: Company Rejects FDA Request To Pull Gene Therapy Elevidys
FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due to safety concerns.
Bill Gates Warns US Cuts To TB Aid Could Lead To 2 Million Additional Deaths Worldwide
Bill Gates, warned the reduce U.S. aid for global TB treatment and diagnosis efforts, can result in at least 2 million additional deaths.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.